180 related articles for article (PubMed ID: 28199203)
21. Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms.
Blum K; Simpatico T; Badgaiyan RD; Demetrovics Z; Fratantonio J; Agan G; Febo M; Gold MS
J Reward Defic Syndr; 2015; 1(2):75-80. PubMed ID: 27617300
[TBL] [Abstract][Full Text] [Related]
22. Combating opiate dependence: a comparison among the available pharmacological options.
Gonzalez G; Oliveto A; Kosten TR
Expert Opin Pharmacother; 2004 Apr; 5(4):713-25. PubMed ID: 15102558
[TBL] [Abstract][Full Text] [Related]
23. Nanotherapeutic approach for opiate addiction using DARPP-32 gene silencing in an animal model of opiate addiction.
Ignatowski TA; Aalinkeel R; Reynolds JL; Nair BB; Sykes DE; Gleason CP; Law WC; Mammen MJ; Prasad PN; Schwartz SA; Mahajan SD
J Neuroimmune Pharmacol; 2015 Mar; 10(1):136-52. PubMed ID: 25604667
[TBL] [Abstract][Full Text] [Related]
24. Animal models for opioid addiction drug discovery.
Grenald SA; Largent-Milnes TM; Vanderah TW
Expert Opin Drug Discov; 2014 Nov; 9(11):1345-54. PubMed ID: 25307021
[TBL] [Abstract][Full Text] [Related]
25. Disruption of the CRF(2) receptor pathway decreases the somatic expression of opiate withdrawal.
Papaleo F; Ghozland S; Ingallinesi M; Roberts AJ; Koob GF; Contarino A
Neuropsychopharmacology; 2008 Nov; 33(12):2878-87. PubMed ID: 18288089
[TBL] [Abstract][Full Text] [Related]
26. Investigation of the neuroanatomical substrates of reward seeking following protracted abstinence in mice.
Madsen HB; Brown RM; Short JL; Lawrence AJ
J Physiol; 2012 May; 590(10):2427-42. PubMed ID: 22393250
[TBL] [Abstract][Full Text] [Related]
27. Pioglitazone attenuates the opioid withdrawal and vulnerability to relapse to heroin seeking in rodents.
de Guglielmo G; Kallupi M; Scuppa G; Demopulos G; Gaitanaris G; Ciccocioppo R
Psychopharmacology (Berl); 2017 Jan; 234(2):223-234. PubMed ID: 27714428
[TBL] [Abstract][Full Text] [Related]
28. Drug abuse: hedonic homeostatic dysregulation.
Koob GF; Le Moal M
Science; 1997 Oct; 278(5335):52-8. PubMed ID: 9311926
[TBL] [Abstract][Full Text] [Related]
29. Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.
Kreek MJ; Levran O; Reed B; Schlussman SD; Zhou Y; Butelman ER
J Clin Invest; 2012 Oct; 122(10):3387-93. PubMed ID: 23023708
[TBL] [Abstract][Full Text] [Related]
30. Impact of synthetic cannabinoids on the duration of opioid-related withdrawal and craving among patients of addiction clinics in Kazakhstan: A prospective case-control study.
Prilutskaya M; Bersani FS; Corazza O; Molchanov S
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631421
[TBL] [Abstract][Full Text] [Related]
31. Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome?
Gold MS; Baron D; Bowirrat A; Blum K
J Neurol Sci; 2020 Nov; 418():117137. PubMed ID: 32957037
[TBL] [Abstract][Full Text] [Related]
32. Opiate exposure state controls dopamine D3 receptor and cdk5/calcineurin signaling in the basolateral amygdala during reward and withdrawal aversion memory formation.
Rosen LG; Rushlow WJ; Laviolette SR
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):59-66. PubMed ID: 28627448
[TBL] [Abstract][Full Text] [Related]
33. Methadone at tapered doses for the management of opioid withdrawal.
Amato L; Davoli M; Ferri M; Ali R
Cochrane Database Syst Rev; 2004 Oct; (4):CD003409. PubMed ID: 15495052
[TBL] [Abstract][Full Text] [Related]
34. Analysis of Opioid-Seeking Behavior Through the Intravenous Self-Administration Reinstatement Model in Rats.
Fattore L; Fadda P; Zanda MT; Fratta W
Methods Mol Biol; 2021; 2201():231-245. PubMed ID: 32975804
[TBL] [Abstract][Full Text] [Related]
35. Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians.
Franchitto N; Jullian B; Salles J; Pelissier F; Rolland B
Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):669-677. PubMed ID: 28343423
[TBL] [Abstract][Full Text] [Related]
36. Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.
Gold MS
Psychiatr Clin North Am; 1993 Mar; 16(1):61-73. PubMed ID: 8456048
[TBL] [Abstract][Full Text] [Related]
37. Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
Blum K; Febo M; Fried L; Li M; Dushaj K; Braverman ER; McLaughlin T; Steinberg B; Badgaiyan RD
Subst Use Misuse; 2017 Mar; 52(4):535-547. PubMed ID: 28033474
[TBL] [Abstract][Full Text] [Related]
38. Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependence.
Blum K; Chen ALC; Thanos PK; Febo M; Demetrovics Z; Dushaj K; Kovoor A; Baron D; Smith DE; Roy AK; Fried L; Chen TJH; Chapman E; Modestino EJ; Steinberg B; Badgaiyan RD
Front Biosci (Elite Ed); 2018 Jan; 10(1):175-196. PubMed ID: 28930612
[TBL] [Abstract][Full Text] [Related]
39. Galanin can attenuate opiate reinforcement and withdrawal.
Picciotto MR; Hawes JJ; Brunzell DH; Zachariou V
Neuropeptides; 2005 Jun; 39(3):313-5. PubMed ID: 15944028
[TBL] [Abstract][Full Text] [Related]
40. Neurobiology of addictive behaviors and its relationship to methadone maintenance.
Stimmel B; Kreek MJ
Mt Sinai J Med; 2000; 67(5-6):375-80. PubMed ID: 11064487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
